Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,989.00p
   
  • Change Today:
      1.00p
  • 52 Week High: 2,088.00p
  • 52 Week Low: 1,767.50p
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 387,165
  • Market Cap: £4,413.32m
  • RiskGrade: 125
  • Beta: 0.65

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

1 Day Chart (24-12-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 2.9% 0.0%
Div Cover 3.1 2.9
Op Mrgn 12.8% 22.8%
ROCE 15.8%  
Latest F'cast
P/E 11.2 11.5
PEG 0.5 n/a
Pr/Revenue 1.9 1.4
Pr/Book 2.5  
Latest F'cast
Revenue 14.2% -14.5%
PBT 20.6% 99.3%
EPS 23.2% -2.2%
DPS 28.6% -34.4%

HIK Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 2,207.00 491.00 150.40¢ 16.6 1.8 +9% 44.00¢ 1.8%
31-Dec-20 2,341.00 558.00 172.90¢ 18.3 1.2 +15% 50.00¢ 1.6%
31-Dec-21 2,553.00 544.00 194.80¢ 14.3 1.1 +13% 54.00¢ 1.9%
31-Dec-22 2,517.00 233.00 181.00¢ 10.8 n/a -7% 56.00¢ 2.9%
31-Dec-23 2,875.00 281.00 223.00¢ 10.1 0.4 +23% 72.00¢ 3.2%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

HIK Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 3,084.10 702.78 173.49p 11.5 n/a -2% 59.27p 0.0%
31-Dec-25 3,214.61 734.36 184.78p 10.8 1.7 +6% 63.03p 0.0%
31-Dec-26 3,335.22 783.27 201.34p 9.9 1.1 +9% 67.46p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

HIK Company Announcements

Director/PDMR Shareholding 23-Dec-2024 09:46 RNS
Outcome of Audit Tender Process 07-Nov-2024 15:30 RNS
Trading Statement 07-Nov-2024 07:00 RNS

HIK ShareCast News

London close: Stocks finish lower as Ashtead ann... 10-Dec-2024 ShareCast
RBC upgrades Hikma Pharmaceuticals to 'outperform' 10-Dec-2024 ShareCast
Hikma reiterates outlook on strong trading 07-Nov-2024 ShareCast

HIK Top Newspaper Links

Hikma boosts injectables business with $300m deal 29-May-2014 Telegraph
MARKET REPORT: Shares jump as Hikma Pharmaceutic... 08-May-2014 Daily Mail
Hikma prepares return to Libya 26-Aug-2011 The Independent

Latest HIK Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

HIK Market Data

Currency UK Pounds
Share Price 1,989.00p
Change Today 1.00p
% Change 0.05 %
52 Week High 2,088.00p
52 Week Low 1,767.50p
Volume 387,165
Shares Issued 221.89m
Market Cap £4,413.32m
Beta 0.65
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.67% below the market average51.67% below the market average51.67% below the market average51.67% below the market average51.67% below the market average
12.00% above the sector average12.00% above the sector average12.00% above the sector average12.00% above the sector average12.00% above the sector average
Price Trend
62.12% above the market average62.12% above the market average62.12% above the market average62.12% above the market average62.12% above the market average
79.59% above the sector average79.59% above the sector average79.59% above the sector average79.59% above the sector average79.59% above the sector average
Income
9.21% above the market average9.21% above the market average9.21% above the market average9.21% above the market average9.21% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
26.48% below the market average26.48% below the market average26.48% below the market average26.48% below the market average26.48% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Interim Final
Ex-Div 15-Aug-24 21-Mar-24
Paid 20-Sep-24 03-May-24
Amount 32.00¢ 47.00¢

Trades for 24-Dec-2024

Time Volume / Share Price
12:54 165,352 @ 1,989.00p
12:54 165,352 @ 1,989.00p
12:42 8,007 @ 1,991.27p
12:35 21,826 @ 1,989.00p
12:35 112 @ 1,989.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page